医学
动脉瘤
帕罗西汀
药品
栓塞
放射科
内科学
药理学
血清素
受体
作者
Shunichi Fukuda,Youko Niwa,Nice Ren,Naohiro Yonemoto,Masato Kasahara,Masahiro Yasaka,Masayuki Ezura,Takumi Asai,Masayuki Miyazono,Masaaki Korai,Keisuke Tsutsumi,Keigo Shigeta,Yuta Oi,Ataru Nishimura,Hitoshi Fukuda,Masanori Goto,Takashi Yoshida,Miyuki Fukuda,Akihiro Yasoda,Koji Iihara
标识
DOI:10.3171/2024.6.jns24714
摘要
Rupture of cerebral aneurysms has a poor prognosis, and growing aneurysms are prone to rupture. Although the number of coil embolization procedures is increasing worldwide, they are more prone to recurrence than clipping surgeries. However, there is still no drug that prevents aneurysm growth or recanalization after coil embolization. The authors have previously focused on the role of hemodynamics in cerebral aneurysm development and reported that inhibition of the P2X4 purinoceptor, by which vascular endothelial cells sense blood flow, reduced the induction and growth of aneurysms in an animal model. In this study, the authors investigated the effects of paroxetine, a P2X4 inhibitor also used as an antidepressant, on aneurysm growth and recanalization after endovascular coiling.
科研通智能强力驱动
Strongly Powered by AbleSci AI